Kevin G. Sarney
CIK: 0001431136
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATRA
Atara Biotherapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Sarney Kevin G
Sarney Kevin G (SEC CIK 0001431136) files insider reports with the SEC as Interim CFO of Atara Biotherapeutics, Inc. (ATRA).
Signal8 holds 1 ownership filing by Sarney Kevin G, a Form 3, filed on Jul 6, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Sarney Kevin G's filings is in THOUSAND OAKS, CA.
Other insiders filing for Atara Biotherapeutics, Inc. (ATRA)
- Cherry Brian N, Director
- Nguyen AnhCo, President and CEO
- Redmile Group, LLC, Director
- HEIDEN WILLIAM K, Director
- Fust Matthew K, Director
- Ciongoli Gregory Austin, Director